Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Penelitian ini bertujuan untuk mempelajari keseluruhan proses dari praktik sekuritisasi aset terkini yang dilakukan oleh Jasa Marga, sebuah BUMN Jalan Tol terbesar di Indonesia. Menjadi menarik karena business nature perusahaan yang tidak memiliki aset keuangan seperti piutang yang dapat disekuritisasi. Hasil penelitian menemukan bahwa aset keuangan yang disekuritisasi ternyata sintetis atau buatan, berupa surat berharga hak atas pendapatan atas salah satu ruas jalan tol di masa mendatang. Selain itu, ditemukan juga bahwa EBA Jasa Marga memiliki praktik yang berbeda dengan EBA pada umumnya serta memiliki finance cost yang lebih tinggi jika dibandingkan dengan obligasi. Dengan demikian, sekuritisasi aset bisa saja dijadikan sebagai alternatif pembiayaan infrastruktur terutama bagi perusahaan dengan tingkat leverage yang tinggi namun perusahaan harus memiliki aset keuangan riil untuk disekuritisasi serta mampu menekan tingginya biaya dalam penerbitan EBA. ......This research aims at studying the entire process of the latest asset securitization practices conducted by Jasa Marga, the biggest Toll Road State Owned Enterprise in Indonesia. It becomes interesting as the business nature of the company who does not have financial assets such as receivables that can be securitized. The results of the study found that securitized financial assets are synthetic or artificial, in the form of securities of rights upon revenues of one of the toll roads in the future. In addition, it was also found that Jasa Marga ABS has different practices compared to ABS in general and has higher financial costs compared to bonds. Therefore, asset securitization may become an infrastructure financing alternative particularly for companies with high leverage ratio but they should have real financial assets to securitized and able to reduce the high costs of issuing ABS.

Abstrak :
This study aims to examine the preference of investors of pharmaceutical companies, including companies that produce herbal medicines, listed in the Indonesian Stock Exchange from 2020 to 2021. By using the descriptive analysis method and reviewing the daily stock prices of Indofarma (INAF), Kimia Farma (KAEF), Kalbe Farma (KLBF), and Sido Muncul (SIDO) in that period, it was found that there were unusual stock prices increases for state-owned pharmaceutical enterprises during those times. However, a similar occurrence did not occur with the other listed pharmaceutical companies, including one herbal medicine manufacturer. In comparing stock price movement trends, the researcher used Microsoft Excel software. The researcher also reviewed the monthly stock closing prices and the news published at that moment. It was found that related events and news existed for every significant increase in stock prices, which might influence investors' perceptions. In addition, the researcher also examined the data to test whether there was a correlation between the number of infected cases and stock prices using the ARCH model estimation. It was found that the relationship between both of them was insignificant. The researcher expects that the findings of this research not only will be a discussion topic in academic groups but also will be a reference for capital market investors and the government as the policyholders and controlling shareholders of these state-owned enterprises. Further studies on listed pharmaceutical companies in the capital markets of other countries are needed to complete the findings in this research, which may find different facts due to different policies in handling the COVID-19 pandemic.